中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Progress in the study of small molecule inhibitors of HSP90

文献类型:期刊论文

作者Ren Jing2; Yan Bibo1; Shi Feng2; Xiong Bing2; Shen Jingkang2
刊名Acta Pharmaceutica Sinica
出版日期2015
卷号50期号:6页码:640-649
关键词HSP90 HSP90 client protein tumor inhibitor
ISSN号0513-4870
其他题名HSP90小分子抑制剂研究进展
文献子类Review
英文摘要HSP90, which is the biomarker of cell stress and endogenous protective protein, functions as a molecular chaperone. Many client proteins of HSP90, including EGFR, Met, Raf-1, IKK and p53, play important roles in the occurrence and development of tumor. Binding of HSP90 inhibitors triggers the deactivation of HSP90, resulting in client protein degradation, and hence inhibits the tumor growth by blocking multiple targets involved in signaling of tumor proliferation. This review summarizes recent development of small molecule inhibitors bound to N-terminal of HSP90.
资助项目国家自然科学基金资助项目[00000000] ; 国家"新药创制"科技重大专项资助项目[00000000]
WOS研究方向Pharmacology & Pharmacy (provided by Clarivate Analytics)
语种中文
CSCD记录号CSCD:5442916
源URL[http://119.78.100.183/handle/2S10ELR8/269281]  
专题药物化学研究室
作者单位1.College of Electronics and Information, Yangtze University, Jingzhou, Hubei 434023, China.
2.State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.;
推荐引用方式
GB/T 7714
Ren Jing,Yan Bibo,Shi Feng,et al. Progress in the study of small molecule inhibitors of HSP90[J]. Acta Pharmaceutica Sinica,2015,50(6):640-649.
APA Ren Jing,Yan Bibo,Shi Feng,Xiong Bing,&Shen Jingkang.(2015).Progress in the study of small molecule inhibitors of HSP90.Acta Pharmaceutica Sinica,50(6),640-649.
MLA Ren Jing,et al."Progress in the study of small molecule inhibitors of HSP90".Acta Pharmaceutica Sinica 50.6(2015):640-649.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。